Psychiatry & Neurology Doctors in Bridgeport, CT Accepting Medicare

36 Psychiatry & Neurology doctors found. Showing 21 - 36

Dr. Rajindar Kaur Mathoda, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Dr. Margarita Munoz, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1558 Barnum Ave, Bridgeport, CT 06610 Phone: 203-384-3377

Helen Lewis Miller, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Mr. Philip Anthony Micalizzi Jr., MD Psychiatry & Neurology - Neurology Medicare: May Accept Medicare Assignments Practice Location: 3180 Main Street, Ste 302, Bridgeport, CT 06606 Phone: 203-372-6505    Fax: 203-372-5622

Rosalba Salamanca, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Roxana Guadalupe Llovet, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Dr. Linda D Wolf, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Tasneem Ahmad Khan, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1635 Central Avenue, Room 213 Southwest Ct Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660    Fax: 203-551-7481

Mr. Jose A Camacho-pantoja, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 46 Albion St, Southwest Community Health Center, Inc, Bridgeport, CT 06605 Phone: 203-330-6000    Fax: 203-330-6008

Fatima Bilal Motiwala, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 1558 Barnum Ave, Bridgeport, CT 06610 Phone: 203-384-3377

Dr. Michele J Feinberg, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3260

Mihaela Florentina Nedelcuta, M D Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3897    Fax: 203-384-3950

Dr. Susannah Audrey Tung, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1635 Central Ave, Bridgeport, CT 06610 Phone: 203-551-7400

David E. Ciancimino, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4697 Main St, Bridgeport, CT 06606 Phone: 203-372-5695    Fax: 203-459-0574

Lei Zou, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3897

David Gianetti, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3715 Main St, Suite 410, Bridgeport, CT 06606 Phone: 203-374-7882

News Archive

Thermo Scientific GENESYS 30 visible-range spectrophotometer simplifies user operation, increases productivity

A new rugged, accurate visible-range spectrophotometer is designed for lab managers and instructors looking for ease of operation and superior photometric performance in a single instrument.

Solgar voluntarily recalls ABC Dophilus Powder

Solgar, Inc., of Leonia, NJ, is voluntarily recalling ABC Dophilus Powder. The recall was initiated, out of an abundance of caution, because the product was found to contain Rhizopus oryzae, which may cause Mucormycosis.

Neurological researchers study promising new treatment for deadly brain tumors

A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.

Clarity Pointe announces groundbreaking of new memory care community in Tallahassee

Clarity Pointe is excited to announce the groundbreaking of its newest memory care community, Clarity Pointe Tallahassee.

Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months: Report

According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)